日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

达雷妥尤单抗、卡非佐米和泊马度胺治疗POEMS综合征：梅奥诊所的经验

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00859-x
Vaxman, I; Kumar, S K; Buadi, F; Lacy, M Q; Dingli, D; Hayman, S; Kourelis, T; Warsame, R; Hwa, Y; Fonder, A; Hobbs, M; Muchtar, E; Leung, N; Kapoor, P; Go, R; Lin, Y; Gonsalves, W; Siddiqui, M; Kyle, R A; Rajkumar, S V; Gertz, M A; Dispenzieri, A
多发性硬化症
发表日期：2023
文献求助 收藏

"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience

梅奥诊所经验：贝兰他单抗治疗复发性多发性骨髓瘤的疗效和安全性“真实世界”数据

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-021-00592-3
Vaxman, I; Abeykoon, J; Dispenzieri, A; Kumar, S K; Buadi, F; Lacy, M Q; Dingli, D; Hwa, Y; Fonder, A; Hobbs, M; Reeder, C; Sher, T; Hayman, S; Kourelis, T; Warsame, R; Muchtar, E; Leung, N; Go, R; Gonsalves, W; Siddiqui, M; Kyle, R A; Rajkumar, S V; Kristen, McCullough; Kapoor, P; Gertz, M A
多发性骨髓瘤
骨髓瘤
发表日期：2021
文献求助 收藏

Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

通过多参数流式细胞术定量循环克隆性浆细胞，可以识别出进展风险高的冒烟型多发性骨髓瘤患者。

期刊:Leukemia
影响因子:13.4
doi:10.1038/leu.2016.205
Gonsalves, W I; Rajkumar, S V; Dispenzieri, A; Dingli, D; Timm, M M; Morice, W G; Lacy, M Q; Buadi, F K; Go, R S; Leung, N; Kapoor, P; Hayman, S R; Lust, J A; Russell, S J; Zeldenrust, S R; Hwa, L; Kourelis, T V; Kyle, R A; Gertz, M A; Kumar, S K
FCM
骨髓瘤
细胞生物学
多发性骨髓瘤
发表日期：2017
文献求助 收藏

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

修订版国际分期系统在未经筛选的新诊断和复发性多发性骨髓瘤患者中的临床应用价值

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2017.13
Tandon, N; Rajkumar, S V; LaPlant, B; Pettinger, A; Lacy, M Q; Dispenzieri, A; Buadi, F K; Gertz, M A; Hayman, S R; Leung, N; Go, R S; Dingli, D; Kapoor, P; Lin, Y; Hwa, Y L; Fonder, A L; Hobbs, M A; Zeldenrust, S R; Lust, J A; Gonsalves, W I; Russell, S J; Kumar, S K
多发性骨髓瘤
骨髓瘤
发表日期：2017
文献求助 收藏

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

新诊断的多发性骨髓瘤诱导治疗期间未受累免疫球蛋白的变化

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2017.46
Ravi, P; Kumar, S; Gonsalves, W; Buadi, F; Lacy, M Q; Go, R S; Dispenzieri, A; Kapoor, P; Lust, J A; Dingli, D; Lin, Y; Russell, S J; Leung, N; Gertz, M A; Kyle, R A; Bergsagel, P L; Rajkumar, S V
多发性骨髓瘤
免疫/内分泌
骨髓瘤
发表日期：2017
文献求助 收藏

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey

一项基于美国国家健康与营养调查的人群研究：10-49岁人群中骨髓瘤前体状态单克隆丙种球蛋白病（意义未明）的患病率

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2017.97
Landgren, O; Graubard, B I; Kumar, S; Kyle, R A; Katzmann, J A; Murata, K; Costello, R; Dispenzieri, A; Caporaso, N; Mailankody, S; Korde, N; Hultcrantz, M; Therneau, T M; Larson, D R; Cerhan, J R; Rajkumar, S V
骨髓瘤
发表日期：2017
文献求助 收藏

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

13号染色体异常及多种细胞遗传学高危异常在初诊多发性骨髓瘤中的预后意义

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2017.83
Binder, M; Rajkumar, S V; Ketterling, R P; Greipp, P T; Dispenzieri, A; Lacy, M Q; Gertz, M A; Buadi, F K; Hayman, S R; Hwa, Y L; Zeldenrust, S R; Lust, J A; Russell, S J; Leung, N; Kapoor, P; Go, R S; Gonsalves, W I; Kyle, R A; Kumar, S K
多发性骨髓瘤
细胞生物学
骨髓瘤
发表日期：2017
文献求助 收藏

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma

多发性骨髓瘤患者细胞遗传学演变的发生及其预后意义

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2016.15
Binder, M; Rajkumar, S V; Ketterling, R P; Dispenzieri, A; Lacy, M Q; Gertz, M A; Buadi, F K; Hayman, S R; Hwa, Y L; Zeldenrust, S R; Lust, J A; Russell, S J; Leung, N; Kapoor, P; Go, R S; Gonsalves, W I; Kyle, R A; Kumar, S K
多发性骨髓瘤
细胞生物学
骨髓瘤
发表日期：2016
文献求助 收藏

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

疾病生物标志物的演变及冒烟型多发性骨髓瘤早期进展风险

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2016.65
Ravi, P; Kumar, S; Larsen, J T; Gonsalves, W; Buadi, F; Lacy, M Q; Go, R; Dispenzieri, A; Kapoor, P; Lust, J A; Dingli, D; Lin, Y; Russell, S J; Leung, N; Gertz, M A; Kyle, R A; Bergsagel, P L; Rajkumar, S V
多发性骨髓瘤
骨髓瘤
发表日期：2016
文献求助 收藏

Prevalence, incidence and survival of smoldering multiple myeloma in the United States

美国冒烟型多发性骨髓瘤的患病率、发病率和生存率

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2016.100
Ravindran, A; Bartley, A C; Holton, S J; Gonsalves, W I; Kapoor, P; Siddiqui, M A; Hashmi, S K; Marshall, A L; Ashrani, A A; Dispenzieri, A; Kyle, R A; Rajkumar, S V; Go, R S
多发性骨髓瘤
骨髓瘤
发表日期：2016
文献求助 收藏